高级检索
当前位置: 首页 > 详情页

Integral-Omics: Serial Extraction and Profiling of Metabolome, Lipidome, Genome, Transcriptome, Whole Proteome and Phosphoproteome Using Biopsy Tissue

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE ◇ 自然指数

机构: [1]Westlake Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, State Key Lab Med Prote, Hangzhou 310006, Zhejiang, Peoples R China [2]Westlake Lab Life Sci & Biomed, Westlake Ctr Intelligent Prote, Hangzhou 310024, Zhejiang, Peoples R China [3]Westlake Univ, Res Ctr Ind Future, Sch Life Sci, Hangzhou 310030, Zhejiang, Peoples R China [4]Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Minimally Invas Surg Ctr, Dept Gen Surg,Sch Med, Shanghai 200025, Peoples R China [5]Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Hongqiao Int Inst Med, Key Lab Cell Differentiat & Apoptosis Chinese,Mini, Shanghai 200025, Peoples R China [6]Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Shanghai 200025, Peoples R China
出处:
ISSN:

摘要:
The integrative multiomics characterization of minute amounts of clinical tissue specimens has become increasingly important. Here, we present an approach called Integral-Omics, which enables sequential extraction of metabolites, lipids, genomic DNA, total RNA, proteins, and phosphopeptides from a single biopsy-level tissue specimen. We benchmarked this method with various samples, applied the workflow to perform multiomics profiling of tissues from six patients with colorectal cancer, and found that tumor tissues exhibited suppressed ferroptosis pathways at multiomics levels. Together, this study presents a methodology that enables sequential extraction and profiling of metabolomics, lipidomics, genomics, transcriptomics, proteomics, and phosphoproteomics using biopsy tissue specimens.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 1 区 化学
小类 | 1 区 分析化学
最新[2025]版:
大类 | 1 区 化学
小类 | 1 区 分析化学
JCR分区:
出版当年[2023]版:
Q1 CHEMISTRY, ANALYTICAL
最新[2023]版:
Q1 CHEMISTRY, ANALYTICAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Westlake Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, State Key Lab Med Prote, Hangzhou 310006, Zhejiang, Peoples R China [2]Westlake Lab Life Sci & Biomed, Westlake Ctr Intelligent Prote, Hangzhou 310024, Zhejiang, Peoples R China [3]Westlake Univ, Res Ctr Ind Future, Sch Life Sci, Hangzhou 310030, Zhejiang, Peoples R China
通讯作者:
通讯机构: [1]Westlake Univ, Affiliated Hangzhou Peoples Hosp 1, Sch Med, State Key Lab Med Prote, Hangzhou 310006, Zhejiang, Peoples R China [2]Westlake Lab Life Sci & Biomed, Westlake Ctr Intelligent Prote, Hangzhou 310024, Zhejiang, Peoples R China [3]Westlake Univ, Res Ctr Ind Future, Sch Life Sci, Hangzhou 310030, Zhejiang, Peoples R China [5]Shanghai Jiao Tong Univ, Shanghai Tongren Hosp, Hongqiao Int Inst Med, Key Lab Cell Differentiat & Apoptosis Chinese,Mini, Shanghai 200025, Peoples R China [6]Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Reprod Med, Shanghai 200025, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25471 今日访问量:0 总访问量:1498 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)